These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34140445)

  • 1. Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Acharya C; Nadhem O; Shaw J; Hassouneh R; Fagan A; McGeorge S; Sterling RK; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles HS; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Am J Gastroenterol; 2021 Dec; 116(12):2385-2389. PubMed ID: 34140445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
    Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
    Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study.
    Miwa T; Hanai T; Hirata S; Nishimura K; Sahashi Y; Unome S; Imai K; Shirakami Y; Suetsugu A; Takai K; Shimizu M
    Clin Nutr ESPEN; 2024 Oct; 63():267-273. PubMed ID: 38972037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
    Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
    Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
    World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
    Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
    Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
    J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy.
    Greinert R; Zipprich A; Simón-Talero M; Stangl F; Ludwig C; Wienke A; Praktiknjo M; Höhne K; Trebicka J; Genescà J; Ripoll C
    Liver Int; 2020 Dec; 40(12):3093-3102. PubMed ID: 32890428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
    Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.